A citation-based method for searching scientific literature

Ahmad Naghibzadeh Tahami, Narges Khanjani, Vahid Yazdi Feyzabadi, Masoomeh Varzandeh, Ali-Akbar Haghdoost. Arch Iran Med 2014
Times Cited: 24







List of co-cited articles
93 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Opium: an emerging risk factor for gastric adenocarcinoma.
Ramin Shakeri, Reza Malekzadeh, Arash Etemadi, Dariush Nasrollahzadeh, Karim Aghcheli, Masoud Sotoudeh, Farhad Islami, Akram Pourshams, Michael Pawlita, Paolo Boffetta,[...]. Int J Cancer 2013
56
58

Opium could be considered an independent risk factor for lung cancer: a case-control study.
Mohammad Reza Masjedi, Parisa Adimi Naghan, Shervin Taslimi, Mahmoud Yousefifard, Seyyed Meisam Ebrahimi, Adnan Khosravi, Shirin Karimi, Mostafa Hosseini, Esmaeil Mortaz. Respiration 2013
42
54

Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophageal cancer in Iran.
M Friesen, I K O'Neill, C Malaveille, L Garren, A Hautefeuille, J R Cabral, D Galendo, C Lasne, M Sala, I Chouroulinkov. Mutat Res 1985
56
50

Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions.
Alireza Sadjadi, Mohammad H Derakhshan, Abbas Yazdanbod, Majid Boreiri, Mahbubeh Parsaeian, Masoud Babaei, Masoomeh Alimohammadian, Fatemeh Samadi, Arash Etemadi, Farhad Pourfarzi,[...]. Int J Cancer 2014
57
50

Opium and risk of laryngeal cancer.
Mohammad Reza Ahamadi Mousavi, Mohammad Ali Damghani, Ali Akbar Haghdoust, Ali Khamesipour. Laryngoscope 2003
57
50

Opium use and risk of mortality from digestive diseases: a prospective cohort study.
Masoud M Malekzadeh, Hooman Khademi, Akram Pourshams, Arash Etemadi, Hossein Poustchi, Mohammad Bagheri, Masoud Khoshnia, Amir Ali Sohrabpour, Ali Aliasgari, Elham Jafari,[...]. Am J Gastroenterol 2013
41
45

Opium use: an emerging risk factor for cancer?
Farin Kamangar, Ramin Shakeri, Reza Malekzadeh, Farhad Islami. Lancet Oncol 2014
49
45

Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran.
Hooman Khademi, Reza Malekzadeh, Akram Pourshams, Elham Jafari, Rasool Salahi, Shahryar Semnani, Behrooz Abaie, Farhad Islami, Siavosh Nasseri-Moghaddam, Arash Etemadi,[...]. BMJ 2012
111
41

Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus.
T Hewer, E Rose, P Ghadirian, M Castegnaro, C Malaveille, H Bartsch, N Day. Lancet 1978
91
41

Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran.
D Nasrollahzadeh, F Kamangar, K Aghcheli, M Sotoudeh, F Islami, C C Abnet, R Shakeri, A Pourshams, H A Marjani, M Nouraie,[...]. Br J Cancer 2008
200
41

Induction of SCE by opium pyrolysates in CHO cells and human peripheral blood lymphocytes.
P E Perry, E J Thomson, Vijayalaxmi, H J Evans, N E Day, H Bartsch. Carcinogenesis 1983
33
37

Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer.
Ramin Shakeri, Farin Kamangar, Mehdi Mohamadnejad, Reza Tabrizi, Farhad Zamani, Ashraf Mohamadkhani, Sepideh Nikfam, Arash Nikmanesh, Masoud Sotoudeh, Rasoul Sotoudehmanesh,[...]. Medicine (Baltimore) 2016
32
37

Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case-control studies.
Ramin Shakeri, Farin Kamangar, Dariush Nasrollahzadeh, Mehdi Nouraie, Hooman Khademi, Arash Etemadi, Farhad Islami, Hajiamin Marjani, Saman Fahimi, Alireza Sepehr,[...]. PLoS One 2012
26
33

Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran.
Morteza Akbari, Ahmad Naghibzadeh-Tahami, Narges Khanjani, Mohammad Reza Baneshi, Elham Kamali, Maryam Hesampour, Bahman Nazemzadegan, Ali-Akbar Haghdoost. Arch Iran Med 2015
17
47

Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study.
Shirin Moossavi, Mehdi Mohamadnejad, Akram Pourshams, Hossein Poustchi, Farhad Islami, Maryam Sharafkhah, Babak Mirminachi, Siavosh Nasseri-Moghaddam, Shahryar Semnani, Ramin Shakeri,[...]. Cancer Epidemiol Biomarkers Prev 2018
17
47

Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran.
Akram Pourshams, Hooman Khademi, Akbar Fazeltabar Malekshah, Farhad Islami, Mehdi Nouraei, Ali Reza Sadjadi, Elham Jafari, Nasser Rakhshani, Rasool Salahi, Shahryar Semnani,[...]. Int J Epidemiol 2010
167
29

Opium consumption and risk of bladder cancer: A case-control analysis.
Seyyed Yousof Hosseini, Mohammad Reza Safarinejad, Erfan Amini, Hassan Hooshyar. Urol Oncol 2010
38
29

Risk factors for lung cancer in Singapore Chinese, a population with high female incidence rates.
R MacLennan, J Da Costa, N E Day, C H Law, Y K Ng, K Shanmugaratnam. Int J Cancer 1977
243
29

Can Opium Use Contribute to a Higher Risk of Colorectal Cancers? A Matched Case-control Study in Iran.
Ahmad Naghibzadeh-Tahami, Vahid Yazdi Feyzabadi, Narges Khanjani, Ahad Ashrafi-Asgarabad, Hosniyeh Alizaeh, Vahid Reza Borhaninejad, Mohammad Moradi-Joo, Masoud Zeinali, Mohammad Javad Zahedi, Mahmoud Aghaee-Afshar,[...]. Iran J Public Health 2016
11
63

Mutagens produced by the pyrolysis of opium and its alkaloids as possible risk factors in cancer of the bladder and oesophagus.
C Malaveille, M Friesen, A M Camus, L Garren, A Hautefeuille, J C Béréziat, P Ghadirian, N E Day, H Bartsch. Carcinogenesis 1982
51
25

Is bladder cancer more common among opium addicts?
M A Aliasgari, A Kaviani, L Gachkar, S R Hosseini-Nassab. Urol J 2004
17
35

Oesophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor.
P Ghadirian, G F Stein, C Gorodetzky, M B Roberfroid, G A Mahon, H Bartsch, N E Day. Int J Cancer 1985
70
25

Opium usage as an etiologic factor of oral cavity cancer.
Ebrahim Razmpa, Babak Saedi, Maziar Motiee-langroudi, Ata Garajei, Sareh Hoseinpor, Mohammad Hosein Kalantar Motamedi. J Craniofac Surg 2014
9
66

Effects of opium consumption on coronary artery disease risk factors and oral health: Results of Kerman Coronary Artery Disease Risk factors Study a population-based survey on 5900 subjects aged 15-75 years.
Hamid Najafipour, Mohammad Masoomi, Armita Shahesmaeili, Ali Akbar Haghdoost, Mahdi Afshari, Hamid Reza Nasri, Masoomeh Kahnooji, Sadra Samadi, Ali Mirzazadeh. Int J Prev Med 2015
28
25

Prominent bladder cancer risk factors in Iran.
Nasser Shakhssalim, Seyed Yousef Hosseini, Abbas Basiri, Babak Eshrati, Maria Mazaheri, Ata Soleimanirahbar. Asian Pac J Cancer Prev 2010
34
20

Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran.
Christian C Abnet, Mitra Saadatian-Elahi, Akram Pourshams, Paolo Boffetta, Ali Feizzadeh, Paul Brennan, Philip R Taylor, Farin Kamangar, Sanford M Dawsey, Reza Malekzadeh. Cancer Epidemiol Biomarkers Prev 2004
85
20

Estimating the prevalence of opiates use by unlinked anonymous urine drug testing: a pilot study in Iran.
Nouzar Nakhaee, Kouros Divsalar, Manzume Shamsi Meimandi, Shahriar Dabiri. Subst Use Misuse 2008
30
20

Opium Addiction and Risk of Laryngeal and Esophageal Carcinoma.
Mehdi Bakhshaee, Hamid Reza Raziee, Reza Afshari, Amin Amali, Mahmoud Roopoosh, Ali Lotfizadeh. Iran J Otorhinolaryngol 2017
8
62

Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study.
Mahdi Sheikh, Ramin Shakeri, Hossein Poustchi, Akram Pourshams, Arash Etemadi, Farhad Islami, Masoud Khoshnia, Abdolsamad Gharavi, Gholamreza Roshandel, Hooman Khademi,[...]. Lancet Glob Health 2020
26
20

Opium: a potential urinary bladder carcinogen in man.
A Sadeghi, S Behmard, S D Vesselinovitch. Cancer 1979
40
16

Presence of lead in opium.
Mahmoud Aghaee-Afshar, Payam Khazaeli, Behzad Behnam, Mohammad Rezazadehkermani, Narges Ashraf-Ganjooei. Arch Iran Med 2008
44
16

Epidemiologic Study of Opium Use in Pars Cohort Study: A Study of 9000 Adults in a Rural Southern Area of Iran.
Mohammad Amin Fallahzadeh, Alireza Salehi, Mojtaba Naghshvarian, Mohammad Hossein Fallahzadeh, Hossein Poustchi, Sadaf G Sepanlou, Abdullah Gandomkar, Reza Malekzadeh. Arch Iran Med 2017
12
33

Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer.
Mahdi Afshari, Ghasem Janbabaei, Mohammad Amin Bahrami, Mahmood Moosazadeh. PLoS One 2017
25
16

Opium Use and Head and Neck Cancers: A Matched Case-Control Study in Iran.
Hosniyeh Alizadeh, Ahmad Naghibzadeh Tahami, Narges Khanjani, Vahid Yazdi-Feyzabadi, Hadi Eslami, Vahidreza Borhaninejad, Mohammad Hasan Larizadeh, Ahmad Enhesari, Reza Abbasi-Rayeni, Vahid Moazed,[...]. Asian Pac J Cancer Prev 2020
8
50

Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China.
Gina D Tran, Xiu-Di Sun, Christian C Abnet, Jin-Hu Fan, Sanford M Dawsey, Zhi-Wei Dong, Steven D Mark, You-Lin Qiao, Philip R Taylor. Int J Cancer 2005
491
12


Radiotherapy of carcinoma of the Larynx.
R Khoo. Ann Acad Med Singap 1981
11
27

Effects of opium consumption on cardiometabolic diseases.
Farzad Masoudkabir, Nizal Sarrafzadegan, Mark J Eisenberg. Nat Rev Cardiol 2013
39
12

Epidemiologic study of oral cancer in Fars Province, Iran.
M S Fahmy, A Sadeghi, S Behmard. Community Dent Oral Epidemiol 1983
21
14

Substance abuse among Iranian high school students.
Saeed Momtazi, Richard Rawson. Curr Opin Psychiatry 2010
76
12



Medicinal aspects of opium as described in Avicenna's Canon of Medicine.
Mojtaba Heydari, Mohammad Hashem Hashempur, Arman Zargaran. Acta Med Hist Adriat 2013
32
12

Correlates of opium use: retrospective analysis of a survey of tribal communities in Arunachal Pradesh, India.
Himanshu K Chaturvedi, Jagadish Mahanta, Ram C Bajpai, Arvind Pandey. BMC Public Health 2013
13
23

Trends in gastrointestinal cancer incidence in Iran, 2001-2010: a joinpoint analysis.
Mehdi Darabi, Mohsen Asadi Lari, Seyed Abbas Motevalian, Ali Motlagh, Shahram Arsang-Jang, Maryam Karimi Jaberi. Epidemiol Health 2016
20
15

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
12

Lead poisoning among opium users in Iran: an emerging health hazard.
Mohammad Mahdi Hayatbakhsh, Zohreh Oghabian, Elvira Conlon, Samaneh Nakhaee, Ali Reza Amirabadizadeh, Mohammad Javad Zahedi, Sodief Darvish Moghadam, Bighan Ahmadi, Somayeh Soroush, Jan Aaseth,[...]. Subst Abuse Treat Prev Policy 2017
38
12

The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer.
Frances E Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, Valeriy A Poroyko, Ravi Salgia, Jonathan Moss, Patrick A Singleton. PLoS One 2014
122
12


Is opium use associated with an increased risk of lung cancer? A case-control study.
Ahmad Naghibzadeh-Tahami, Maryam Marzban, Vahid Yazdi-Feyzabadi, Shahryar Dabiri, Shokrollah Mohseni, Reza Abbasi Rayeni, Mitra Samareh Fekri, Mohammad Hasan Larizadeh, Behnaz Karimpour, Narges Khanjani. BMC Cancer 2020
6
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.